Global Age-related Macular Degeneration In-Depth Advance Market 2017-2020
 |
| Age-related Macular Degeneration |
Albany, New York, Apr 04, 2017
"Global
Age-related Macular Degeneration Market 2017-2020"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
About
AMD
AMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops into wet AMD. Dry AMD occurs when small, yellowish deposits called drusen start accumulating beneath the macula. While some treatments are available for wet AMD; there is no treatment available at the moment for dry AMD.
AMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops into wet AMD. Dry AMD occurs when small, yellowish deposits called drusen start accumulating beneath the macula. While some treatments are available for wet AMD; there is no treatment available at the moment for dry AMD.
** Technavios analysts forecast the global age-related macular degeneration (AMD) market to grow at a CAGR of 7.37% during the period 2017-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global age-related macular degeneration (AMD) market for 2017-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of AMD.
– The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Age-Related Macular Degeneration (AMD) Market 2017-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
– Key vendors
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
– Other prominent vendors
Alcon
Allergan
Adverum Biotechnologies
Bausch + Lomb
Gilead Sciences
Iconic Therapeutics
Lpath
Neurotech Pharmaceuticals
Ohr Pharmaceutical
Opthea
Ophthotech
PanOptica
Pfizer
Promedior
QLT
Quark
Resolvyx Pharmaceuticals
RXi Pharmaceuticals
Sagent Pharmaceuticals
Santen Pharmaceuticals
Sanwa Kagaku Kenkyusho
– Market driver
Increasing reimbursement benefits for AMD drugs
For a full, detailed list, view our report
– Market challenge
Availability of alternative therapies
For a full, detailed list, view our report
– Market trend
Novel treatment approaches for developing AMD drugs
For a full, detailed list, view our report
– Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Comments
Post a Comment